Role of kinase-independent and -dependent functions of FAK in endothelial cell survival and barrier function during embryonic development
暂无分享,去创建一个
Ann Y Park | J. Guan | Shaogang Sun | Xu Peng | Xiaofeng Zhao | Ann Y. Park
[1] J. Girault,et al. Autophosphorylation-independent and -dependent Functions of Focal Adhesion Kinase during Development* , 2009, The Journal of Biological Chemistry.
[2] T. Hunter. Tyrosine phosphorylation: thirty years and counting. , 2009, Current opinion in cell biology.
[3] Tony Pawson,et al. Kinome signaling through regulated protein-protein interactions in normal and cancer cells. , 2009, Current opinion in cell biology.
[4] F. Orsenigo,et al. The role of adherens junctions and VE-cadherin in the control of vascular permeability , 2008, Journal of Cell Science.
[5] Matthew D. Wessel,et al. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. , 2008, Cancer research.
[6] Susan J Fisher,et al. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. , 2008, Molecular cell.
[7] M. Lampugnani,et al. Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration , 2008, Journal of Cell Science.
[8] Liz Y. Han,et al. Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. , 2007, Cancer research.
[9] J. V. van Buul,et al. ICAM-1-Mediated, Src- and Pyk2-Dependent Vascular Endothelial Cadherin Tyrosine Phosphorylation Is Required for Leukocyte Transendothelial Migration1 , 2007, The Journal of Immunology.
[10] Christopher Autry,et al. Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor* , 2007, Journal of Biological Chemistry.
[11] J. Gutkind,et al. VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin , 2006, Nature Cell Biology.
[12] S. Hanks,et al. The Signaling and Biological Implications of FAK Overexpression in Cancer , 2006, Clinical Cancer Research.
[13] R. Braren,et al. Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation , 2006, The Journal of cell biology.
[14] J. Guan,et al. Mechanisms of focal adhesion kinase regulation. , 2005, Current cancer drug targets.
[15] D. Cheresh,et al. Tyrosine Phosphorylation of VE-cadherin Prevents Binding of p120- and β-Catenin and Maintains the Cellular Mesenchymal State* , 2005, Journal of Biological Chemistry.
[16] R. Flavell,et al. Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis , 2005, The Journal of cell biology.
[17] J. Cross,et al. Development of structures and transport functions in the mouse placenta. , 2005, Physiology.
[18] H. Ueda,et al. Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice. , 2004, Cardiovascular research.
[19] D. Schlaepfer,et al. Multiple connections link FAK to cell motility and invasion. , 2004, Current opinion in genetics & development.
[20] H. Dvorak,et al. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. , 2003, The American journal of pathology.
[21] J. Parsons,et al. Focal adhesion kinase: the first ten years , 2003, Journal of Cell Science.
[22] E. Wagner,et al. Heterogeneity of bronchial endothelial cell permeability. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[23] M. Corada,et al. VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. , 2002, Molecular biology of the cell.
[24] M. Schaller. Biochemical signals and biological responses elicited by the focal adhesion kinase. , 2001, Biochimica et biophysica acta.
[25] R. Flavell,et al. Conditional Vascular Cell Adhesion Molecule 1 Deletion in Mice , 2001, The Journal of experimental medicine.
[26] S. Hanks,et al. Anti-apoptotic Role of Focal Adhesion Kinase (FAK): Induction of Inhibitor-of-Apoptosis Proteins and Apoptosis Suppression by the Overexpression of FAK in a Human Leukemic Cell Line, HL-60 , 2000 .
[27] S. Hanks,et al. Anti-apoptotic Role of Focal Adhesion Kinase (FAK) , 2000, The Journal of Biological Chemistry.
[28] E. Shevach,et al. Cbl-b regulates the CD28 dependence of T-cell activation , 2000, Nature.
[29] W. Skarnes. Gene trapping methods for the identification and functional analysis of cell surface proteins in mice. , 2000, Methods in enzymology.
[30] M. Tang,et al. Suppression of Ultraviolet Irradiation-induced Apoptosis by Overexpression of Focal Adhesion Kinase in Madin-Darby Canine Kidney Cells* , 1999, The Journal of Biological Chemistry.
[31] John Calvin Reed,et al. Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells , 1999, Oncogene.
[32] M. Corada,et al. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. , 1998, Journal of cell science.
[33] T. Hunter,et al. Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells , 1998, Oncogene.
[34] E. Abel. Clinical applications of research on angiogenesis , 1996 .
[35] E. Ruoslahti,et al. Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.
[36] F. Alt,et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Wood,et al. Targeted disruption of the pituitary glycoprotein hormone alpha-subunit produces hypogonadal and hypothyroid mice. , 1995, Genes & development.
[38] B. Geiger,et al. The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha- catenin with vascular endothelial cadherin (VE-cadherin) , 1995, The Journal of cell biology.
[39] J. Folkman. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. , 1995, The New England journal of medicine.
[40] Robertson Rp. Seminars in medicine of the Beth Israel Hospital, Boston: Pancreatic and islet transplantation for diabetes--cures or curiosities? , 1992 .